Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000515792 | SCV001572876 | uncertain significance | Phenylketonuria | 2021-03-26 | reviewed by expert panel | curation | The c.506G>C (p.Arg169Pro) variant in PAH is reported as Likely Pathogenic by one clinical laboratory in ClinVar (see variant ID 446524); no further information is provided. At the time of review, the variant does not appear to be reported in the published literature and/or in the BioPKU database. The variant is predicted damaging by multiple lines of computational evidence (PP3). It is absent in gnomAD (PM2). Other missense variants at this site are pathogenic/likely pathogenic – p.Arg169Ser (variant ID 932262), p.Arg169His (variant ID 102706), p.Arg169Gly (variant ID 551103), and p.Arg169Cys (variant ID 125436) (PM5). In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PM5, PP3. |
Medical Genetics Center, |
RCV000515792 | SCV000611630 | likely pathogenic | Phenylketonuria | 2017-10-18 | no assertion criteria provided | clinical testing | The mutation has been detected in compound heterozygous state with another pathogenic mutation (c.506G>C) in a 5 years old girl affected with PKU and was found in heterozygous in her father. |